Sonoma Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing healing solutions for dermatological conditions and advanced wound care. The primary purpose of this entity is to create non-toxic therapies that safely reduce infections and inflammation, accelerating the body's natural healing processes. Its product portfolio includes a range of topical anti-infective treatments and skin care solutions tailored for various fields, including dermatology, wound care, eye care, and animal health. Sonoma's formulations commonly feature hypochlorous acid, an element known for its antimicrobial and soothing properties. Significantly impacting the healthcare and pharmaceutical sectors, Sonoma Pharmaceuticals addresses critical needs in infection management and chronic wound therapy. The company’s innovations are particularly beneficial in hospital settings, outpatient clinics, and home care, offering versatile treatment options for both human and animal patients. Headquartered in Boulder, Colorado, the company's reach extends internationally, underscoring its role as a key player in improving patient outcomes through scientifically-backed therapeutic products.